Strategic Overview

Molbio Diagnostics is a pioneer in point-of-care molecular diagnostics. Headquartered in Goa, India, the company developed Truenat, a portable, battery-operated, IoT-enabled real-time PCR platform recognized globally for TB detection and drug susceptibility testing.

Innovation Portfolio

Truenat MTB Ultima
Category: DIAGNOSIS Stage: Late Stage

Innovative diagnostic solution.

nPOC Molecular Swab/Sputum
Truenat MTB-INH
Category: DRUG RESIST. Stage: Commercial

Innovative diagnostic solution.

Molecular Sputum

Key Milestones

WHO endorsed Truenat as first point-of-care rapid molecular diagnostic platform for TB diagnosis (2020)
Deployed in 85+ countries across 8,293+ NAAT systems in India
Received Kochon Prize from Stop TB Partnership (2025)
Raised $85 million from Temasek for global expansion
Provides diagnostics for 30+ diseases including TB, COVID-19, HIV, dengue, malaria